Published in Crit Care on October 21, 2011
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. Physiol Rev (2015) 1.20
Critical illness polyneuropathy and myopathy: a systematic review. Neural Regen Res (2014) 0.88
Dose and type of crystalloid fluid therapy in adult hospitalized patients. Perioper Med (Lond) (2013) 0.82
Early prediction of intensive care unit-acquired weakness using easily available parameters: a prospective observational study. PLoS One (2014) 0.77
Year in review 2011: Critical Care--Neurocritical care. Crit Care (2012) 0.75
Critical illness polyneuropathy (CIP) in neurological early rehabilitation: clinical and neurophysiological features. BMC Neurol (2016) 0.75
Calcium supplementation improves clinical outcome in intensive care unit patients: a propensity score matched analysis of a large clinical database MIMIC-II. Springerplus (2015) 0.75
The action of calcium on the electrical properties of squid axons. J Physiol (1957) 35.98
Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology (2005) 3.27
Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med (2001) 2.94
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med (1997) 2.64
Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med (2001) 2.19
A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med (2009) 1.96
Neuromuscular manifestations of critical illness. Muscle Nerve (2005) 1.88
Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol (1998) 1.84
Human sepsis increases lymphocyte intracellular calcium. Crit Care Med (1993) 1.68
Extracellular calcium controls background current and neuronal excitability via an UNC79-UNC80-NALCN cation channel complex. Neuron (2010) 1.66
Alterations in intracellular Ca2+-homeostasis of skeletal muscle fibers during sepsis. Crit Care Med (2008) 1.57
Effects of chronic sepsis on the voltage-gated sodium channel in isolated rat muscle fibers. Crit Care Med (2007) 1.53
Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis. Eur J Neurol (2006) 1.51
Muscle membrane dysfunction in critical illness myopathy assessed by velocity recovery cycles. Clin Neurophysiol (2010) 1.45
Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation (1997) 1.45
Hypocalcemia: a pervasive metabolic abnormality in the critically ill. Am J Kidney Dis (2001) 1.42
Prevalence and predictive value of ionized hypocalcemia among critically ill patients. Acta Anaesthesiol Scand (2003) 1.33
Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism. FASEB J (1999) 1.31
Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit. Acta Neurol Scand (2008) 1.28
Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology (2006) 1.28
Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol (2001) 1.18
Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care (2010) 1.14
Signs of critical illness polyneuropathy and myopathy can be seen early in the ICU course. Acta Anaesthesiol Scand (2009) 0.95
Brief review: Nondepolarizing neuromuscular blocking drugs and critical illness myopathy. Can J Anaesth (2006) 0.87
Neuromuscular symptoms in elderly patients with hyperparathyroidism: improvement with parathyroid surgery. Med J Aust (1988) 0.85
Hypocalcemic myopathy in idiopathic hypoparathyroidism. Eur J Pediatr (1982) 0.84
Non-familial primary hyperparathyroidism. Semin Surg Oncol (1997) 0.83
Hypocalcemic induced increase in creatine kinase in rats. Pediatr Neurol (1998) 0.82
Neurologic complications of thyroid and parathyroid disease. Med Clin North Am (1993) 0.81
Diagnosis and management of critical illness polyneuropathy and critical illness myopathy. Curr Treat Options Neurol (2007) 0.79
Critical illness polyneuropathy in patients with major burn injuries. Eplasty (2010) 0.78
Elevated muscle enzymes and muscle biopsy in idiopathic hypoparathyroidism patients. J Endocrinol Invest (2011) 0.76
High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury. Chest (2005) 3.58
Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother (2005) 2.47
β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis (2011) 2.03
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother (2007) 1.89
Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials. Lancet Infect Dis (2005) 1.89
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents (2009) 1.88
Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis (2005) 1.70
Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med (2008) 1.69
Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials. Br J Haematol (2005) 1.60
Potential of old-generation antibiotics to address current need for new antibiotics. Expert Rev Anti Infect Ther (2008) 1.56
Microbiologically documented nosocomial infections after coronary artery bypass surgery without cardiopulmonary bypass. J Thorac Cardiovasc Surg (2006) 1.45
Toxicity after prolonged (more than four weeks) administration of intravenous colistin. BMC Infect Dis (2005) 1.40
Cefuroxime as antibiotic prophylaxis in coronary artery bypass grafting surgery. Interact Cardiovasc Thorac Surg (2007) 1.39
Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents (2008) 1.36
Nephrotoxicity of intravenous colistin: a prospective evaluation. Int J Antimicrob Agents (2005) 1.36
Patterns and early evolution of organ failure in the intensive care unit and their relation to outcome. Crit Care (2012) 1.26
Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials. Mayo Clin Proc (2005) 1.20
The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Clin Med Res (2006) 1.14
Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime. J Infect (2007) 1.09
Outcome of critically ill oldest-old patients (aged 90 and older) admitted to the intensive care unit. J Am Geriatr Soc (2006) 1.04
Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med (2006) 1.03
Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series. Respir Med (2008) 0.95
Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates. Int J Antimicrob Agents (2007) 0.94
Infections of respiratory or abdominal origin in ICU patients: what are the differences? Crit Care (2010) 0.91
Aspergillus fumigatus tricuspid native valve endocarditis in a non-intravenous drug user. J Med Microbiol (2006) 0.90
Rhinocerebral mucormycosis in a patient with cirrhosis and chronic renal failure. Hepatogastroenterology (2003) 0.88
Polymyxins: old antibiotics are back. Lancet (2006) 0.86
Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials. Crit Care (2006) 0.86
Plesiomonas shigelloides sepsis in a thalassemia intermedia patient. Scand J Infect Dis (2002) 0.84
Alterations in biomarkers of endothelial function following on-pump coronary artery revascularization. J Clin Lab Anal (2010) 0.79
Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia. PLoS One (2011) 0.78
Treatment of acute bacterial exacerbations of chronic bronchitis. Expert Opin Pharmacother (2009) 0.78
Knowledge and practices regarding prevention of infections associated with central venous catheters: a survey of intensive care unit medical and nursing staff. Am J Infect Control (2011) 0.77
Nosocomial infections after off-pump coronary artery bypass surgery: frequency, characteristics, and risk factors. Interact Cardiovasc Thorac Surg (2007) 0.76
Inadequate statistical power of published comparative cohort studies on ventilator-associated pneumonia to detect mortality differences. Clin Infect Dis (2010) 0.76
The significance of different formulations of aerosolized colistin. Crit Care (2005) 0.76
Benefits of aerosolized colistin for ventilator-associated pneumonia: absence of proof versus proof of absence? Clin Infect Dis (2011) 0.75
Risk factors for isolation of strains susceptible only to polymyxin among patients with Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother (2006) 0.75
Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence. Int J Antimicrob Agents (2011) 0.75
Predictors of early postoperative atrial fibrillation after off-pump myocardial revascularization. Innovations (Phila) (2007) 0.75
Pulmonary drug delivery systems for antimicrobial agents: facts and myths. Int J Antimicrob Agents (2009) 0.75
Perioperative Adverse Respiratory Events in Overweight/Obese Children: Systematic Review. J Perianesth Nurs (2016) 0.75
Treatment of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii pneumonia. J Cyst Fibros (2005) 0.75
Open-access world wide web resources on sepsis. Clin Infect Dis (2008) 0.75
Polymyxins: a word of caution for prudent use of valuable "old antibiotics". Infect Control Hosp Epidemiol (2006) 0.75
Optimal duration of the antimicrobial treatment of ventilator-acquired pneumonia. Expert Rev Anti Infect Ther (2008) 0.75